Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases

BACKGROUND: It is still controversial whether primary tumor resection (PTR) improves survival in colorectal cancer (CRC) patients with unresectable metastases. METHODS: Colon cancer patients were enrolled and randomly allocated to with or without PTR after induction chemotherapy with XELOX or mFOLFO...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Mingzhu, Yang, Ya’nan, Li, Qingguo, Wang, Chenchen, Liang, Lei, Zhu, Xiaodong, Zhang, Wen, Chen, Zhiyu, Huang, Dan, Li, Wenhua, Zhang, Xiaowei, Zhao, Xiaoying, Qiu, Lixin, Geng, Qirong, Yu, Nuoya, Du, Wenfang, Sun, Sijie, Sheng, Xuedan, Li, Xinxiang, Guo, Weijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841852/
https://www.ncbi.nlm.nih.gov/pubmed/35174078
http://dx.doi.org/10.3389/fonc.2022.747124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841852/
https://www.ncbi.nlm.nih.gov/pubmed/35174078
http://dx.doi.org/10.3389/fonc.2022.747124

Ejemplares similares